Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Esther, Sala"'
Autor:
Adam Hospital, Genís Bayarri, Stian Soiland- Reyes, Douglas Lowe, Josep Lluís Gelpí, Pau Andrio, Daniele Lezzi, Jorge Ejarque, Sarah Butcher, Ania Niewielska, Alberto Eusebi, Esther Sala, Aristarc Surinach, Martí Municoy, Rosa Maria Badia, Rodrigo Vargas, Alexandre Bonvin
This deliverable presents the final release of demonstration workflows for the BioExcel-2 project, including a wrap-up of all the work done for the BioBB library, its associated workflows, and a final analysis of the milestones achieved from the init
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d5f4016c8cff24b7fe30a2d40d696d
Autor:
Laura Guasch, Esther Sala, Miquel Mulero, Cristina Valls, Maria Josepa Salvadó, Gerard Pujadas, Santiago Garcia-Vallvé
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55889 (2013)
BACKGROUND: Natural extracts have played an important role in the prevention and treatment of diseases and are important sources for drug discovery. However, to be effectively used in these processes, natural extracts must be characterized through th
Externí odkaz:
https://doaj.org/article/010d74af62764799acd8af0c5e56fb6e
Autor:
Laura Guasch, Maria José Ojeda, Noemí González-Abuín, Esther Sala, Adrià Cereto-Massagué, Miquel Mulero, Cristina Valls, Montserrat Pinent, Anna Ardévol, Santiago Garcia-Vallvé, Gerard Pujadas
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44971 (2012)
BACKGROUND: There has been great interest in determining whether natural products show biological activity toward protein targets of pharmacological relevance. One target of particular interest is DPP-IV whose most important substrates are incretins
Externí odkaz:
https://doaj.org/article/09231d19921e451dad5dbeba41da3269
Autor:
Laura Guasch, Esther Sala, Anna Castell-Auví, Lidia Cedó, Klaus R Liedl, Gerhard Wolber, Markus Muehlbacher, Miquel Mulero, Montserrat Pinent, Anna Ardévol, Cristina Valls, Gerard Pujadas, Santiago Garcia-Vallvé
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e50816 (2012)
BACKGROUND: Although there are successful examples of the discovery of new PPARγ agonists, it has recently been of great interest to identify new PPARγ partial agonists that do not present the adverse side effects caused by PPARγ full agonists. Co
Externí odkaz:
https://doaj.org/article/265703f2a5904960adfacc5fd9cc55e7
Autor:
Laura Guasch, Esther Sala, María José Ojeda, Cristina Valls, Cinta Bladé, Miquel Mulero, Mayte Blay, Anna Ardévol, Santiago Garcia-Vallvé, Gerard Pujadas
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44972 (2012)
BACKGROUND: Natural extracts play an important role in traditional medicines for the treatment of diabetes mellitus and are also an essential resource for new drug discovery. Dipeptidyl peptidase IV (DPP-IV) inhibitors are potential candidates for th
Externí odkaz:
https://doaj.org/article/2f69fc45d24d42d2b3cf41f71fb2ef81
Autor:
Thomas Walther, Esther Sala, Kinga Gebolys, Jenny Eichhorst, Óscar Villacañas, Maura Naughton, Anja Tetzner
Publikováno v:
European Journal of Pharmacology. 833:116-123
The heptapeptide angiotensin (Ang)-(1-7) is part of the beneficial arm of the renin-angiotensin system. Ang-(1-7) has cardiovascular protective effects, stimulates regeneration, and opposes the often detrimental effects of AngII. We recently identifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e5033e8390b1b8e124b3651ebf244f
https://doi.org/10.1016/j.ejphar.2018.05.031
https://doi.org/10.1016/j.ejphar.2018.05.031
Autor:
Esther Sala, Laura Guasch, Justyna Iwaszkiewicz, Miquel Mulero, Maria-Josepa Salvadó, Montserrat Pinent, Vincent Zoete, Aurélien Grosdidier, Santiago Garcia-Vallvé, Olivier Michielin, Gerard Pujadas
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e16903 (2011)
BackgroundTheir large scaffold diversity and properties, such as structural complexity and drug similarity, form the basis of claims that natural products are ideal starting points for drug design and development. Consequently, there has been great i
Externí odkaz:
https://doaj.org/article/6e2af70bae44479cbe1f505beba0d545
Autor:
Esther Sala-Barat, Joaquín Tomás-Sábado, Kate E. Webster, Pedro Álvarez-Díaz, Eduard Alentorn-Geli, Ramón Cugat
Publikováno v:
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA. 28(3)
To translate into Spanish and validate the anterior cruciate ligament-return to sport after injury (ACL-RSI) scale, and to evaluate the psychological factors that have the greatest impact on the return to play among Spanish football players. The ACL-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bba9e995858bf76cb9960956175a5db
https://pubmed.ncbi.nlm.nih.gov/32399615
https://pubmed.ncbi.nlm.nih.gov/32399615
Autor:
Anja, Tetzner, Maura, Naughton, Kinga, Gebolys, Jenny, Eichhorst, Esther, Sala, Óscar, Villacañas, Thomas, Walther
Publikováno v:
European journal of pharmacology. 833
The heptapeptide angiotensin (Ang)-(1-7) is part of the beneficial arm of the renin-angiotensin system. Ang-(1-7) has cardiovascular protective effects, stimulates regeneration, and opposes the often detrimental effects of AngII. We recently identifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9ca03ba4e8bbe63af19653c09cdc02b8
https://pubmed.ncbi.nlm.nih.gov/29792841
https://pubmed.ncbi.nlm.nih.gov/29792841
Publikováno v:
Hypertension. 70
Background: It is well accepted that Compound 21 (C21) is a highly selective non-peptide angiotensin AT2 receptor agonist. C21 as well as angiotensin (Ang)-(1-7) have cardiovascular protective effects and are opponents of the often detrimental Ang II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fd8ffc70001c2e34145d392a9107f68
https://doi.org/10.1161/hyp.70.suppl_1.p237
https://doi.org/10.1161/hyp.70.suppl_1.p237